It works by binding directly to IGF-1 receptors on muscle cells, activating pathways like PI3K/Akt that trigger protein synthesis, cellular proliferation, and satellite cell activation.
IGF-1 LR3 (Insulin-Like Growth Factor 1 Long Arg3) is a synthetic analog of naturally occurring IGF-1 designed with structural modifications—including an 13-amino acid extension—that significantly increase its biological half-life and potency. While it is a popular subject of research for muscle hypertrophy and tissue repair, its online purchase and use are subject to strict legal and safety regulations. Structure: It is an 83-amino acid analog of human IGF-1.
Unlike native IGF-1, which has a half-life of roughly 12–15 hours, LR3 has a half-life of 20–30 hours . It also has a reduced affinity for binding proteins, allowing it to remain bioactive in the bloodstream much longer. Research Applications and Reported Benefits
Scientific studies and medically supervised therapies often explore IGF-1 LR3 for the following purposes: